Patents by Inventor Caina LI

Caina LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156889
    Abstract: The present disclosure relates a method for reducing animal weight, comprising administering to a patient in need thereof a therapeutically or prophylactically effective amount of a mulberry extract. The mulberry extract comprises: 3% to 99% of an alkaloid, 0.2% to 70% of a polysaccharide, 0% to 50% of an amino acid, 0% to 10% of flavone, and 0% to 25% of other components. The mulberry extract of the present disclosure can be used for controlling weight gain, and has a good therapeutic effect on type 2 diabetes with obesity.
    Type: Application
    Filed: March 11, 2022
    Publication date: May 16, 2024
    Inventors: Yuling LIU, Yanmin CHEN, Zhihua LIU, Xiangyang ZHU, Yiqun JIN, Hongzhen YANG, Tingting WANG, Yuanyuan LIU, Zhufang SHEN, Shuainan LIU, Quan LIU, Chunfang LIAN, Qianwen SUN, Yuanyuan ZOU, Caina LI, Lei LEI, Hui CAO
  • Publication number: 20230416329
    Abstract: Provided are a polypeptide containing disulfide bonds and capable of inhibiting activity of serine protease, and a use thereof, relating to three types of linear polypeptide molecules, respectively capable of inhibiting the activity of small intestine protein metabolic enzymes such as trypsin, chymotrypsin, and elastase. Said polypeptide molecules may be broadly fused to another polypeptide or protein drug capable of treating a disease, so as to form a hybrid peptide. The hybrid peptide may inhibit the degradation of metabolic enzymes to improve the stability of a peptide or protein drug for treating a disease, such that the curative effect of direct injection administration is improved, while also facilitating direct administration absorption of the polypeptide or protein drug in the small intestine, and implementing oral administration of the protein polypeptide drug.
    Type: Application
    Filed: November 29, 2021
    Publication date: December 28, 2023
    Inventors: Wei WANG, Zhufang SHEN, Minzhi LIU, Caina LI, Sujuan SUN, Ying MA, Hui CAO, Haijing ZHANG, Yan YANG, Lianqiu WU